Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma.

Chen Wang Matthew S Block Julie M Cunningham Mark E Sherman Bryan M McCauley Sebastian M Armasu Robert A Vierkant Nadia Traficantenull nullAline Talhouk Susan J Ramus Nadja Pejovic Martin Koebel Brooke D Jorgensen Dale W Garsed Sian Fereday Jennifer Anne Doherty Dinuka Ariyaratne Michael S Anglesio Martin Widschwendter Tanja Pejovic Jesus Gonzalez Bosquet David D L Bowtell Stacey J Winham Ellen L Goode

Published in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2023)

This work aids in identification of targetable epigenome processes and stratification of patients for whom tailored treatment may be most beneficial.

Keyphrases

high grade
end stage renal disease
dna methylation
low grade
ejection fraction
newly diagnosed
peritoneal dialysis
prognostic factors
genome wide
patient reported outcomes
smoking cessation
patient reported